adplus-dvertising
Connect with us

News

China blamed for Canada’s multimillion-dollar coronavirus vaccine deal collapse – Global News

Published

 on


Editors note: CanSino Biologics provided a response to Global News after this story was published.

As China races to develop a COVID-19 vaccine, a multimillion-dollar collaboration between Canada and China has failed, likely because of Beijing’s geopolitical concerns, say scientists with direct knowledge of the project.

This week Canada’s National Research Council (NRC) announced it has abandoned its partnership with Chinese company CanSino Biologics, because China’s government continues to block shipments of vaccine materials to Canada.

Read more:
Canada-China COVID-19 vaccine trials abandoned: National Research Council

The NRC — which is part of the Minister of Innovation, Science and Industry — has received about $44-million since late March to upgrade its production capacity in Montreal in preparation for materials expected from CanSino.

Story continues below advertisement

Now the NRC says it is working with two other COVID-19 vaccine collaborators including the United States company VBI Vaccines.

“With the funding received from the Government of Canada on March 23 and April 23, much work is underway at NRC … to certify our facility … and expand production,” NRC stated. “These enhancements to the facility will support a broad range of partners and clients with research, scale-up support, and the manufacturing of vaccines and therapeutics.”

In May, Prime Minister Justin Trudeau endorsed the deal with CanSino —  a company funded by Beijing and producing its vaccine with the People’s Liberation Army.

Read more:
Canadian minister promises review after security contracts awarded to Chinese-state tech company

CanSino’s COVID-19 vaccine is being tested on Chinese soldiers and has been approved for testing at the Canadian Center for Vaccinology (CCfV) at Dalhousie University in Halifax. CanSino’s vaccine was supposed to arrive at the CCfV in June.

But after Canada signed the CanSino deal “the Government of China changed rules on shipping vaccines,” the NRC said this week in a statement.






2:21
Russia approves first coronavirus vaccine, but scientists are skeptical


Russia approves first coronavirus vaccine, but scientists are skeptical

CanSino was founded in 2009 by Chinese scientist Dr. Xuefeng Yu, who was educated at McGill University in Quebec and worked for Sanofi Pasteur, before returning to China.

Story continues below advertisement

Yu did not respond to interview requests from Global News, but this week reportedly told the Globe and Mail that “bureaucratic indecision” from Chinese officials has delayed shipments of CanSino’s vaccine to Canada.

After this story was published CanSino issued this statement: “Up to the date of this announcement, the collaboration between the National Research Council of Canada and the Company has not been terminated. None of the management of the Company has accepted any interview in relation to the clinical trails (sic) for Ad5-nCoV in Canada in the recent period; and the Company is currently driving the international multi-center phase III clinical trial for Ad5-nCoV with several countries.”

Read more:
United Front groups in Canada helped Beijing stockpile coronavirus safety supplies

The failed collaboration was based upon the NRC providing CanSino a license to use Canada’s proprietary biological product HEK293, a line of cells that CanSino has previously used with the Chinese military to develop a vaccine for the Ebola virus.

In an interview CCfV director Scott Halperin said “the collaboration between CanSino and (CCfV) and NRC was excellent.”

“The vaccine was caught up in Chinese customs, and CanSino did everything they were asked to, but the approvals never came through.”

Halperin said the key benefit to Canadians — if the CanSino vaccine had passed testing at Dalhousie — was Canadians would have been front of the line with a guaranteed supply of the CanSino vaccine, produced in Canada by the NRC.

Story continues below advertisement






7:09
How close are we to developing a coronavirus vaccine?


How close are we to developing a coronavirus vaccine?

Halperin and another leading Canadian vaccine researcher, Gary Kobinger, said geopolitical competition appears to have destroyed the Canada-China vaccine partnership.

“We can’t think of any other reason the vaccine was not shipped,” Halperin said.

“Getting politics involved into a vaccine is never good,” Kobinger said. “Whether it’s the Chinese government or the Chinese army or the Canadian government (responsible for the CanSino deal failure) I think it’s unfortunate that politicians are building walls.”

Read more:
Canadian mayors may have unwittingly been targets of Chinese influence campaign

Margaret McCuaig-Johnston — a former Canadian assistant-deputy minister responsible for vaccine collaborations with China — said she believes senior Chinese officials have blocked the CanSino shipments in order to retaliate against Canada for the Meng Wanzhou extradition case, or simply to pursue their geopolitical objectives of becoming a world-leading vaccine provider.

Story continues below advertisement

McCuaig-Johnston said in her experience China has previously used customs blockages as a tool in trade disputes, but only top Chinese officials have the authority to take such actions.

McCuaig-Johnston said she was one of the Canadian officials that signed onto an agreement with China in 2007, to share vaccine and technology research. And the partnership was once promising, she said.

“This was a surprise to see our commitment to China, in sharing very significant proprietary intellectual property, run into this major blockage,” McCuaig-Johnston said. “China’s success in vaccines is standing on the back of Canadian researchers and scientists. Over the years we helped China develop its capacity. But China is no longer a reliable partner.”

McCuaig-Johnston says that Canada should broadly reassess any significant research partnerships with China, as evidence mounts that President Xi Jinping’s regime uses international collaboration in order to modernize the People’s Liberation Army and protect the Chinese Communist Party’s interests. And Canadian researchers need to be educated about Xi’s goals.

Read more:
Potential COVID-19 vaccine still not in Canada, three months after approval for trials

McCuaig-Johnston says she briefs Canadian scientists working on artificial intelligence (AI)  — a field where Beijing plans to dominate by 2025 — on the risks of collaboration.

“When I talk to Canadian AI scientists, they often say ‘I have partnered with my Chinese friends, they would never steal from us,’” McCuaig-Johnston said. “I say ‘yes they would. Unfortunately, that is how China’s system works.’”

Story continues below advertisement






3:43
CSIS believes Canada to be a ‘permissive target’ for China’s interference


CSIS believes Canada to be a ‘permissive target’ for China’s interference

Public Safety Canada has not answered a question from Global News on whether Canadian intelligence agencies provided any warnings about risks related to the CanSino vaccine partnership.

But even in March — before Canada committed to a vaccine partnership — there was ample public reporting indicating that China was racing for the vaccine finish line, alone.

CanSino’s military partner, Major General Chen Wei, was portrayed in Chinese-state media as a so-called “wolf warrior” that could bring glory to Beijing.

“A vaccine is the most powerful weapon to end the novel coronavirus,” Chen was quoted on Chinese state TV in March, the Los Angeles Times reported. “If China is the first to develop this weapon with its own intellectual property rights, it will demonstrate not only the progress of Chinese science and technology, but also our image as a major power.”

Story continues below advertisement

Chen and CanSino had already leveraged Canadian research to develop an Ebola vaccine based on the HEK293 cell-line first licensed by the NRC to CanSino, in 2014.

Meanwhile, Halperin says he still hopes to work with CanSino on their vaccine test results from a distance, although Canada’s chance to secure CanSino vaccine supply has been lost.

© 2020 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

News

RCMP arrest second suspect in deadly shooting east of Calgary

Published

 on

 

EDMONTON – RCMP say a second suspect has been arrested in the killing of an Alberta county worker.

Mounties say 28-year-old Elijah Strawberry was taken into custody Friday at a house on O’Chiese First Nation.

Colin Hough, a worker with Rocky View County, was shot and killed while on the job on a rural road east of Calgary on Aug. 6.

Another man who worked for Fortis Alberta was shot and wounded, and RCMP said the suspects fled in a Rocky View County work truck.

Police later arrested Arthur Wayne Penner, 35, and charged him with first-degree murder and attempted murder, and a warrant was issued for Strawberry’s arrest.

RCMP also said there was a $10,000 reward for information leading to the arrest of Strawberry, describing him as armed and dangerous.

Chief Supt. Roberta McKale, told a news conference in Edmonton that officers had received tips and information over the last few weeks.

“I don’t know of many members that when were stopped, fuelling up our vehicles, we weren’t keeping an eye out, looking for him,” she said.

But officers had been investigating other cases when they found Strawberry.

“Our investigators were in O’Chiese First Nation at a residence on another matter and the major crimes unit was there working another file and ended up locating him hiding in the residence,” McKale said.

While an investigation is still underway, RCMP say they’re confident both suspects in the case are in police custody.

This report by The Canadian Press was first published Sept. 13, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

News

26-year-old son is accused of his father’s murder on B.C.’s Sunshine Coast

Published

 on

RICHMOND, B.C. – The Integrated Homicide Investigation Team says the 26-year-old son of a man found dead on British Columbia’s Sunshine Coast has been charged with his murder.

Police say 58-year-old Henry Doyle was found badly injured on a forest service road in Egmont last September and died of his injuries.

The homicide team took over when the BC Coroners Service said the man’s death was suspicious.

It says in a statement that the BC Prosecution Service has approved one count of first-degree murder against the man’s son, Jackson Doyle.

Police say the accused will remain in custody until at least his next court appearance.

The homicide team says investigators remained committed to solving the case with the help of the community of Egmont, the RCMP on the Sunshine Coast and in Richmond, and the Vancouver Police Department.

This report by The Canadian Press was first published Sept. 13, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Metro Vancouver’s HandyDART strike continues after talks break with no deal

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, have broken off without an agreement following 15 hours of talks.

Joe McCann, president of Amalgamated Transit Union Local 1724, says they stayed at the bargaining table with help from a mediator until 2 a.m. Friday and made “some progress.”

However, he says the union negotiators didn’t get an offer that they could recommend to the membership.

McCann says that in some ways they are close to an agreement, but in other areas they are “miles apart.”

About 600 employees of the door-to-door transit service for people who can’t navigate the conventional transit system have been on strike since last week, pausing service for all but essential medical trips.

McCann asks HandyDART users to be “patient,” since they are trying to get not only a fair contract for workers but also a better service for customers.

He says it’s unclear when the talks will resume, but he hopes next week at the latest.

The employer, Transdev, didn’t reply to an interview request before publication.

This report by The Canadian Press was first published Sept. 13, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending